期刊文献+

铝敏化依诺沙星荧光显微成像体系性质及其应用研究 被引量:2

Property and Application of Aluminum-Sensitized Enoxacin Fluorescent Microscopic Imaging System
下载PDF
导出
摘要 应用毛细流自组装成环荧光显微成像技术,建立了铝敏化依诺沙星的测定方法,并实测了不同样品中依诺沙星的浓度。在NH3-NH4Cl缓冲介质(pH9.7)和聚乙烯醇(PVA-124)存在下,Al3+-ENX复合物液滴在疏水性玻璃表面上受热挥发形成直径约为1.63mm,环线宽约为50μm的自组装环。当点样体积为0.20μL,其线性范围1.00×10-13~5.00×10-13mol/ring(5.00×10-7~2.50×10-6mol/L),检出限为7.65×10-15mol/ring(3.83×10-8mol/L)。本方法用于葡萄糖酸依诺沙星注射液中依诺沙星含量和牛奶中依诺沙星残留量的检测,回收率分别为96.9%~107.0%和94.2%~102.5%,相对标准偏差(RSD)分别小于4.1%和2.4%。实测了健康志愿者服用依诺沙星胶囊后尿液中依诺沙星的平均浓度及兔子灌喂依诺沙星后血清中药物平均浓度,均得到了较满意的结果。 The self-ordered ring (SOR) fluorescent microscopic imaging technique has been applied to the determination of the concentration of aluminum-sensitized enoxacin (ENX) in different samples based on the capillary effect of solvent on solid supports.In the presence of NH3-NH4Cl buffer solution (pH 9.70) and PVA-124,the droplet of Al3+-ENX chelate can form a SOR on solid supports with the diameter of 1.63 mm and its ring belt width of 50 μm.The quantitative analysis of enoxacin is achieved with the linear range of 1.00×10^-13-5.00×10^-13mol per ring(5.00×10^-7-2.50×10^-6 mol/L) and limit of detection 7.65×10^-15mol per ring(3.83×10^-8 mol/L) when 0.20 μL droplet was spotted.The technique has been applied to the determination of enoxacin in the enoxacin gluconate injection and residue in four different milk samples with the recoveries of 96.9%-107.0% and 94.2%-102.5%,RSD less than 4.1% and 2.4%,respectively.The enoxacin average concentration in healthy volunteer′s urine and rabbit serum after oral administration was satisfactorily determined with satisfactory result.
出处 《分析化学》 SCIE EI CAS CSCD 北大核心 2010年第7期973-978,共6页 Chinese Journal of Analytical Chemistry
基金 国家自然科学基金(No.20767004) 中央民族大学"985工程"项目(No.MUC985) 中央民族大学"211工程"项目(No.MUC021211306) 中央民族大学引进人才启动基金 内蒙古自治区自然科学基金重点项目(No.200711020202) 内蒙古自治区高等学校科学研究项目(No.NJ06108)资助
关键词 荧光显微成像技术 铝敏化依诺沙星 牛奶 人体尿液 兔子血清 Fluorescent microscopic technique Aluminum-sensitized enoxacin Milk Human urine Rabbit serum
  • 相关文献

参考文献18

  • 1Pharmacopoeia Commission(国家药典委员会).The Pharmacopoeia of the People′s Republic of China(中华人民共和国药典).Beijing(北京):Chemistry and Chemical Engineering Press (化学工业出版社),2005:346.
  • 2CHEN Xin-Qian(陈新谦),JIN You-Yu(金有豫),TANG Guang(汤光).A New Pharmacology(新编药物学).Beijing(北京):People′s Medical Publishing House (人民卫生出版社),2007:105.
  • 3DU Li-Ming(杜黎明),WU Hao(吴昊),CHEN Cai-Ping(陈彩萍).Analysis and Applications of Quinolones(喹诺酮类药物的分析方法与应用).Beijing(北京):Science Press(科学出版社),2006:164.
  • 4Matthias F,Agnieszka K,Thuy D T V,Wolfgang B.J.Chromatogr.A,2004,1047(2):305-311.
  • 5Bucknall S,Silverlight J,Coldham N.Food Addit.Contam.,2003,20 (3):221-228.
  • 6Guido E P,Graziella C,Ettore C.Anal.Chim.Acta,2004,520(1-2):13-18.
  • 7Hassouan M K,Ballesteros O,Zafra A,Vílchez J L,Navalón A.J.Chromatogr.,B,2007,859(2):282-288.
  • 8Samanidou V F,Demetriou C E,Papadoyannis I N.Anal.Bioanal.Chem.,2003,375(5):623-629.
  • 9代钢,敖登高娃.同步荧光光谱法测定尿液中依诺沙星含量[J].光谱学与光谱分析,2005,25(10):1634-1636. 被引量:11
  • 10Liu Y,Huang C Z,Li Y F.Anal.Chem.,2002,74(21):5564-5568.

二级参考文献55

共引文献37

同被引文献16

  • 1Nelson J M,Chiller T M,Powers J H,et al.Clin.Infect.Dis.,2007,44(7): 977.
  • 2Samanidou V F,Demetriou C E,Papadoyannis I N.Anal.Biochem.,2003,375(5): 623.
  • 3Magno A G T,Glaucia M S,Valdir S F.Microchem.J.,2005,81: 209.
  • 4Hernández M,Borrull F,Calull M.Electrophoresis,2002,23(3): 506.
  • 5Sunderland J,Tobin C M,Hedges A J,et al.J.Antimicrob.Chemother.,2001,47(3): 271.
  • 6Fan M K,Huang C Z,Li Y F.Anal.Chim.Acta,2002,453(1): 97.
  • 7Chen Y C,Huang C Z.Talanta,2003,59: 681.
  • 8Liu Y,Huang C Z,Li Y F.Anal.Chem.2002,(74): 5564.
  • 9Huang C Z,Liu Y,Li Y F.J.Pharm.Biomed.Anal.,2004,34: 103.
  • 10Pharmacopoeia Committee of Ministry of Health,the People’s Republic of China(中华人民共和国药典编委会).The Pharmacopoeia of People’s Republic of China(PartⅡ) (中华人民共和国药典二部).Beijing: Chemical Industry Press(北京:化学工业出版社),2000.712.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部